Doctors test combo therapy to protect new lungs from Patient's own immune system
NCT ID NCT03798860
Summary
This study monitored a treatment for lung transplant patients whose bodies developed harmful antibodies against their new organ. It followed 340 patients to see if a combination of antibody-cleaning therapies could remove these damaging antibodies. The goal was to help the transplanted lung survive longer and prevent the body from rejecting it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery
Hanover, Germany
Conditions
Explore the condition pages connected to this study.